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NOTES AND COMMENTS 
In Vitro Kidney Preservation Techniques 
S. G. Dienst, M.D.* 
The advantages of adding hyperbaria, low flow perfusion, and protein colloid 
to hypothermia at 0° C for kidney preservation are described. The possibilities of 
longer preservation at higher temperatures are discussed. 
The preferred method of handling 
the donor kidney during transplanta-
tion continues to be rapid cooling by 
flushing the kidney's vascular bed with 
cold solutions, then holding its temper-
ature at 0° C by surface cooling. With 
certain adjuncts, this technique offers 
good preservation of renal function for 
eight hours. A longer period of reliable 
preservation would allow for transpor-
tation and wider use of potential human 
donor kidneys. Reports of successful 
24-hour preservation, using continuous 
plasma perfusion and oxygenation at 
temperatures of 8° to 10°C,' have en-
couraged studies of these techniques 
and various modifications of them. 
Hypothermic preservation in its sim-
plest form consist of flushing the kid-
ney with cold isomotic electrolyte solu-
tion such as Ringer's lactate. Heparin 
is added to prevent intravascular clot-
ting. After the blood has been flushed 
from the vascular bed, the kidney is 
immersed in a partiaUy frozen saline 
solution or "saline slush." It is stored 
* General Surgery Division I I 
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in this solution for periods as long as 
six to eight hours until anastomosed to 
the vessels of the recipient. In our ex-
perience the kidney thus handled does 
not retain all of its potential function. 
Certain additives and adjuncts have 
improved the immediate response and 
final function of the kidney. 
Table I 
Agents added to initial kidney flushing solution for preservation at 0 C. 
ADDITIVES RATIONALE 
Potassium Ptiosphate (or Chloride) 
Magnesium 
Phenoxybenzamine 
Glucose and Citrate 
Hydrocortisone 
Cnlorpromazine (Thorazine! 
formal oncotic pressure 
Reduce extra-intracellular 
ion gradients 
To conserve mitochondrial 
ATP and DPN* 
Reduce arterial spasm 
Oxidative substrates 
Stabilize lysozome and 
cellular membranes 
• Adenosine Triphosphate and Diphosphopyridine 
Nucleotide 
Albumin or plasma is used to main-
tain a normal oncotic pressure gradient 
between the extra and intracellular 
compartments. This minimizes cellular 
swelling during hypothermia. This is 
better accomplished with albumin* 
* In practice, concentrated "Albumisol" or 
other human albumin is added to the intra-
cellular electrolyte solution to give a six 
gram percent protein solution. 
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than with dextran. Kidneys perfused 
with albumin solution at 0° C have an 
immediate uniform pink color when re-
vascularized. On the other hand, kid-
neys perfused with dextran in an elec-
trolyte solution have a persistent bluish 
cast and do not warm rapidly, indicat-
ing poor perfusion. Also, angiograms 
of the kidneys perfused with dextran 
indicate obstruction of small arteries, 
particularly in the medullary portion.^ 
Composition of the Perfusate 
Potassium phosphate or chloride is 
added to reduce the intra-extraceUular 
gradient of sodium and potassium. This 
is done to conserve the energy normally 
expended to maintain these gradients. 
Also, it has been shown that intracellu-
lar potassium is rapidly lost from cells 
into cold perfusing solutions.^ Magne-
siimi is added to reduce intracellular 
losses, to inhibit ATPase, and to mini-
mize the loss of ATP and DPN from 
mitochondria. Free magnesium is also 
necessary for the activity of many res-
piratory enzymes. Phenoxybenzamine 
is a long acting alpha-adrenergic block-
ing agent used to prevent arterial spasm. 
Recent proponents for the use of pheno-
xybenzamine now advocate giving it 
systemically to a cadaver donor. The 
use of phenoxybenzamine, magesium, 
and potassium is taken from the 
recent work of Collins, Bravo-Shugar-
man and Teraski.* This "intracel-
lular" solution has been used success-
fully as a flushing solution but not yet 
as a continuously flowing perfusate. 
Hydrocortisone and chlorpromazine 
are sometimes added to reduce the 
breakdown of lysozome and cell mem-
branes. Glucose is added as an anaero-
bic supply of DPNH (hydrogen ions) 
through glycolysis. Citrate provides a 
Kreb's cycle substrate. 
For preservation longer than two 
hours, intermittent low flow perfusion 
and hyperbaria are carried out with the 
simple Swenko* apparatus. Until now, 
this perfusate has been a saline base 
solution with only four mEq/1 of mag-
nesium and no added potassium. A 
flow of 200 milliliters per hour under 
three atmospheres of oxygen delivers 8 
miUiliters of dissolved oxygen. This is 
more than is used by the human kidney 
of average weight at 0°C to 1 °C. Aside 
from increasing oxygen delivery, hy-
perbaria somehow extends preservation 
through its pressure effect, possibly by 
minimizing cellular edema. The slow 
flow of perfusate also supplies constant 
substrate and lowers the very high 
PC02's which occur. The uniformly 
better results with perfusion and hyper-
baria suggest that the kidney at 0°C is 
capable of respiration and sufficient 
energy production to keep its molecu-
lar organization intact. Figure 1 shows 
a typical response of the BUN in a pa-
tient after receiving a kidney stored 
under hyperbaria. 
Current Techniques 
During the 20 to 40 minutes of vas-
cular anastomosis, the kidney is grad-
ually warming toward the temperature 
in the operative field. The greatest tem-
perature increase is evidenced in the 
kidney cortex, which normally has the 
highest metabolic rate. To prevent this 
warming during the ischemia period, a 
double wall silastic kidney cooling 
jacket has been designed. This allows 
for the circulation of cold solution 
around the kidney during anastomosis. 
* Swenko Incorporated, Minneapolis. 
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HYPOTHERMIA AND HYPERBARIA 8 HOURS 
Figure 1 
Chart shows the ability to clear urea of the 
donor kidney stored under hyperbaria. 
Its ability to preserve function in the 
transplanted kidney is being evaluated 
in the laboratory. A human size cooling 
jacket* has been used during transplant 
of one cadaver (five hours total stor-
age) and one living related kidney do-
nation. Both patients had receive Man-
nitol. There was prompt diuresis of 
over a liter during the first hour. Blood 
urea nitrogen and serum creatinines 
were normal within 36 hours and both 
kidneys later had above normal cre-
atinine clearances. 
The use of the "intracellular" solu-
tion before storage at 0°C* for a period 
of 24 hours has not been uniformly 
successful in the laboratory. After auto-
transplantation, these canine kidneys 
perfused well and produced urine im-
mediately. However, even the best re-
sults show moderately elevated BUNs 
and creatinines which began to climb 
rapidly after five to seven days. The 
final specimens showed diffuse paren-
chymal damage. 
Perfusion of the kidney at higher 
temperatures appears to be the method 
which is now evolving for longer preser-
vation. Figure 2 outlines a system in-
corporating oxygenation and dialysis of 
the perfusate. In this Extracorporeal 
circuit only cryoprecipitated plasma, 
after the method of Belzer,^  or heavily 
citrated plasma or serum wUl flow 
through the kidney for 24 hours or 
more. In our experience microclotting 
is an important factor in the vascular 
obstruction which is prone to occur. 
Also, perfusion pressures over 50 to 60 
millimeters of mercury are associated 
with increasing edema and resistance to 
flow. Generally, low pressures and low 
temperatures (less than 8°C) yield the 
best perfusion. 
Effects of Temperature 
Temperature seems to be the most 
important variable in these experi-
ments. With plasma perfusate, the tem-
perature is limited to less than 14°C 
because plasma alone cannot transport 
the larger volumes of oxygen required 
at higher temperatures. This narrow 
range, 6°C to 14°C, has the disad-
vantage of retarding respiration and 
02 CO;: 
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* Extracorporeal, New Jersey. 
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KIDNEY PERFUSION 
Figure 2 
Diagrammatic presentation of the method 
for perfusing kidneys at 10°C. The perfusate 
is serum or more commonly cryoprecipitated 




phosphorylation and yet does not give 
the full stabilizing effect of keeping 
these systems near freezing. This com-
promise may prove to be the limiting 
factor in the method. 
Current experiments are designed to 
measure respiration by oxygen con-
sumption while varying the tempera-
ture. The temperatures wUl be carried 
to between 20 °C and 28°C by adding 
red cells or free hemoglobin to the per-
fusate for increased oxygen transport. 
- ConlrolleD level; of Melaholic Intermeiliates - Programmed lemperalure — 
Oxygen Delivery and Electrolyte 
KIDNEY PRESERVATION METHODS 
Figure 3 
Effective preservation time which can be 
achieved with different techniques. Perfusion 
at physiological flow rates and moderately 
reduced temperatures appears to be the most 
promising method for reliable preservation 
beyond 12 hours. 
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